内窥管处理动脉硬化动脉栓塞和主动脉弓狭窄:一中心分析的中期结果

Stefan Müller-Hülsbeck, Marcus Both, Nikolas Charalambous, Philipp J. Schäfer, Martin Heller, Thomas Jahnke
{"title":"内窥管处理动脉硬化动脉栓塞和主动脉弓狭窄:一中心分析的中期结果","authors":"Stefan Müller-Hülsbeck,&nbsp;Marcus Both,&nbsp;Nikolas Charalambous,&nbsp;Philipp J. Schäfer,&nbsp;Martin Heller,&nbsp;Thomas Jahnke","doi":"10.1016/j.rontge.2006.05.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To determine mid-term patency rates after endovascular treatment of supraaortic atherosclerotic arterial stenoses and occlusions using percutaneous transluminal angioplasty (PTA) and stent placement.</p></div><div><h3>Patients and Methods</h3><p>During a period of 83 months, 48 patients (18 female, 30 male; mean age 61 years, range 31–82 years) were included into this prospective single-center study. Fifty-five lesions of the brachial and cephalic arteries (subclavian/axillary artery <em>n</em>=42, innominate artery <em>n</em>=7, origin common carotid artery <em>n</em>=6) were treated using PTA (<em>n</em>=38), PTA plus stent (<em>n</em>=11) or primary stent placement (<em>n</em>=6). For anticoagulation, patients received a bolus of heparin (5000<!--> <!-->IU) intraarterially during the intervention followed by intravenous application for 24<!--> <!-->h. At discharge, life-time application of ASA (100<!--> <!-->mg/day) was initiated. Follow-up protocol included clinical examination, colour-coded duplex ultrasound and intraarterial angiography in case of re-stenosis.</p></div><div><h3>Results</h3><p>PTA and stent placement were technically successful in all patients (100%). No major complications occurred. Of seven patients presenting with total occlusions, six were treated with stent placement. Stent implantation was also performed in all lesions located at the origin of the supraaortic arteries (<em>n</em>=6). In 38 lesions, the result of PTA was satisfactory. Mean follow-up time is 22 months (range 1–83 months). During follow-up examinations, re-stenoses occurred in 10 cases (at 1 month <em>n</em>=2, at 6 months <em>n</em>=2, at 12 months <em>n</em>=3, at 24 months <em>n</em>=3). In 9 lesions, re-interventions were performed (PTA <em>n</em>=7; PTA plus stent <em>n</em>=2). According to Kaplan–Meier life-table analysis, cumulative primary and primary assisted patency rates are 69.5% (patients at risk <em>n</em>=15; standard error 9%) and 90.6% (patients at risk <em>n</em>=16; standard error 6.3%) at 20 months, respectively.</p></div><div><h3>Conclusions</h3><p>Endovascular treatment of atherosclerotic obstructive disease in brachial and cephalic arteries is a safe procedure showing promising mid-term patency rates.</p></div>","PeriodicalId":76505,"journal":{"name":"Rontgenpraxis; Zeitschrift fur radiologische Technik","volume":"56 4","pages":"Pages 119-128"},"PeriodicalIF":0.0000,"publicationDate":"2007-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rontge.2006.05.004","citationCount":"10","resultStr":"{\"title\":\"Endovaskuläre Behandlung arteriosklerotisch bedingter arterieller Stenosen und Okklusionen der Aortenbogengefäße: Mittelfristige Ergebnisse einer Ein-Center-Analyse\",\"authors\":\"Stefan Müller-Hülsbeck,&nbsp;Marcus Both,&nbsp;Nikolas Charalambous,&nbsp;Philipp J. Schäfer,&nbsp;Martin Heller,&nbsp;Thomas Jahnke\",\"doi\":\"10.1016/j.rontge.2006.05.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>To determine mid-term patency rates after endovascular treatment of supraaortic atherosclerotic arterial stenoses and occlusions using percutaneous transluminal angioplasty (PTA) and stent placement.</p></div><div><h3>Patients and Methods</h3><p>During a period of 83 months, 48 patients (18 female, 30 male; mean age 61 years, range 31–82 years) were included into this prospective single-center study. Fifty-five lesions of the brachial and cephalic arteries (subclavian/axillary artery <em>n</em>=42, innominate artery <em>n</em>=7, origin common carotid artery <em>n</em>=6) were treated using PTA (<em>n</em>=38), PTA plus stent (<em>n</em>=11) or primary stent placement (<em>n</em>=6). For anticoagulation, patients received a bolus of heparin (5000<!--> <!-->IU) intraarterially during the intervention followed by intravenous application for 24<!--> <!-->h. At discharge, life-time application of ASA (100<!--> <!-->mg/day) was initiated. Follow-up protocol included clinical examination, colour-coded duplex ultrasound and intraarterial angiography in case of re-stenosis.</p></div><div><h3>Results</h3><p>PTA and stent placement were technically successful in all patients (100%). No major complications occurred. Of seven patients presenting with total occlusions, six were treated with stent placement. Stent implantation was also performed in all lesions located at the origin of the supraaortic arteries (<em>n</em>=6). In 38 lesions, the result of PTA was satisfactory. Mean follow-up time is 22 months (range 1–83 months). During follow-up examinations, re-stenoses occurred in 10 cases (at 1 month <em>n</em>=2, at 6 months <em>n</em>=2, at 12 months <em>n</em>=3, at 24 months <em>n</em>=3). In 9 lesions, re-interventions were performed (PTA <em>n</em>=7; PTA plus stent <em>n</em>=2). According to Kaplan–Meier life-table analysis, cumulative primary and primary assisted patency rates are 69.5% (patients at risk <em>n</em>=15; standard error 9%) and 90.6% (patients at risk <em>n</em>=16; standard error 6.3%) at 20 months, respectively.</p></div><div><h3>Conclusions</h3><p>Endovascular treatment of atherosclerotic obstructive disease in brachial and cephalic arteries is a safe procedure showing promising mid-term patency rates.</p></div>\",\"PeriodicalId\":76505,\"journal\":{\"name\":\"Rontgenpraxis; Zeitschrift fur radiologische Technik\",\"volume\":\"56 4\",\"pages\":\"Pages 119-128\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-03-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.rontge.2006.05.004\",\"citationCount\":\"10\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rontgenpraxis; Zeitschrift fur radiologische Technik\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0035782006000176\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rontgenpraxis; Zeitschrift fur radiologische Technik","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0035782006000176","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 10

摘要

目的探讨经皮腔内血管成形术(PTA)和支架置入术治疗主动脉上动脉粥样硬化性狭窄和闭塞后的中期通畅率。患者与方法在83个月的时间里,48例患者(女性18例,男性30例;平均年龄61岁(范围31-82岁)纳入这项前瞻性单中心研究。55例肱和头侧动脉病变(锁骨下/腋窝动脉42例,无名动脉7例,颈总动脉起源6例)采用PTA(38例)、PTA联合支架(11例)或单纯支架置入术(6例)治疗。对于抗凝,患者在干预期间接受肝素(5000 IU)动脉内注射,随后静脉注射24小时。出院时,开始终身应用ASA (100 mg/天)。随访方案包括临床检查、彩色编码双超及再次狭窄时的动脉内血管造影。结果spta和支架置入术在技术上均成功(100%)。无重大并发症发生。在7例出现全闭塞的患者中,6例接受支架置入术治疗。所有位于主动脉上动脉起源的病变均行支架植入术(n=6)。在38个病变中,PTA的效果令人满意。平均随访时间22个月(范围1 ~ 83个月)。在随访检查中,10例发生再狭窄(1个月n=2, 6个月n=2, 12个月n=3, 24个月n=3)。在9个病变中,进行了再次干预(PTA n=7;PTA +支架n=2)。根据Kaplan-Meier生命表分析,累积原发性和原发性辅助通畅率为69.5%(风险患者n=15;标准误差9%)和90.6%(风险患者n=16;标准误差为6.3%)。结论血管内治疗肱动脉和头动脉粥样硬化性阻塞性疾病是一种安全的手术方法,中期通畅率较高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Endovaskuläre Behandlung arteriosklerotisch bedingter arterieller Stenosen und Okklusionen der Aortenbogengefäße: Mittelfristige Ergebnisse einer Ein-Center-Analyse

Objective

To determine mid-term patency rates after endovascular treatment of supraaortic atherosclerotic arterial stenoses and occlusions using percutaneous transluminal angioplasty (PTA) and stent placement.

Patients and Methods

During a period of 83 months, 48 patients (18 female, 30 male; mean age 61 years, range 31–82 years) were included into this prospective single-center study. Fifty-five lesions of the brachial and cephalic arteries (subclavian/axillary artery n=42, innominate artery n=7, origin common carotid artery n=6) were treated using PTA (n=38), PTA plus stent (n=11) or primary stent placement (n=6). For anticoagulation, patients received a bolus of heparin (5000 IU) intraarterially during the intervention followed by intravenous application for 24 h. At discharge, life-time application of ASA (100 mg/day) was initiated. Follow-up protocol included clinical examination, colour-coded duplex ultrasound and intraarterial angiography in case of re-stenosis.

Results

PTA and stent placement were technically successful in all patients (100%). No major complications occurred. Of seven patients presenting with total occlusions, six were treated with stent placement. Stent implantation was also performed in all lesions located at the origin of the supraaortic arteries (n=6). In 38 lesions, the result of PTA was satisfactory. Mean follow-up time is 22 months (range 1–83 months). During follow-up examinations, re-stenoses occurred in 10 cases (at 1 month n=2, at 6 months n=2, at 12 months n=3, at 24 months n=3). In 9 lesions, re-interventions were performed (PTA n=7; PTA plus stent n=2). According to Kaplan–Meier life-table analysis, cumulative primary and primary assisted patency rates are 69.5% (patients at risk n=15; standard error 9%) and 90.6% (patients at risk n=16; standard error 6.3%) at 20 months, respectively.

Conclusions

Endovascular treatment of atherosclerotic obstructive disease in brachial and cephalic arteries is a safe procedure showing promising mid-term patency rates.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信